Marea Therapeutics

Marea Therapeutics is a private, clinical-stage biotechnology company that uses human genetic data to identify and develop new therapies for cardiometabolic diseases. It focuses on patients who remain at risk of heart attacks even after traditional risk factors such as obesity and elevated LDL cholesterol are controlled. It is advancing several discovery programs built on human genetics and other validated targets.